New Alzheimer's Drug Candidate Enters Human Trials
The oral treatment aims to address Alzheimer's pathology in a newly launched Phase 1 clinical study.
Live Poll
Should pharmaceutical research prioritize early disease prevention over the treatment of existing symptoms?